What are NewcelX AG's key financial statements?

According to the latest financial statement (Form-10K), NewcelX AG has a total asset of $0, Net loss of $0

What are the key financial ratios for NCEL?

NewcelX AG's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is NewcelX AG's revenue broken down by segment or geography?

Currently NewcelX AG data is not available.

Is NewcelX AG profitable?

no, according to the latest financial statements, NewcelX AG has a net loss of $0

Does NewcelX AG have any liabilities?

no, NewcelX AG has liability of 0

How many outstanding shares for NewcelX AG?

NewcelX AG has a total outstanding shares of 0

NCEL Financials: NewcelX AG AI Analysis



Financials

NCEL Financial

NewcelX AG

$3.25

2.2%

$0.06

As of today:May 20, 16:55:05 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$3.18

Open

$3.24

Day's Range

$3.1 - $3.31

52 week range

$1.82 - $30.8

Volume

4.8K

Avg.Volume

80.6K

Dividend yield

EPS (TTM)

-5.27

Market Cap

$14.8M

What is NCEL?

NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The firm offers products like Quilience, which is a clinical-stage pharmaceutical compound. The company aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The firm also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The firm is a publicly traded company, listing on the NASDAQ.

Features

Markets

News

Breakdown	TTM	06/30/2025	12/31/2024	06/30/2024	12/31/2023	06/30/2023
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	3	1	1	1	2	3
Research & Development	0	0	0	0	1	4
Operating Expenses	3	1	1	2	4	7
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-2	-2	0	-2	-4	-7
Income Tax Expense	--	--	--	--	--	--
Net Income	-6	-4	-2	-2	-4	-7
Net Income Growth	0%	100%	-50%	-71%	-43%	-13%
Shares Outstanding (Diluted)	0.4	0.4	0.2	0.1	0.09	0.09
Shares Change (YoY)	282%	282%	113.99%	10%	63%	140%
EPS (Diluted)	-15.51	-10.46	-9.91	-19.41	-47.77	-79.76
EPS Growth	-75%	-46%	-79%	-76%	-64%	-63%
Free Cash Flow	-4	-2	-2	-1	-2	-7
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-3	-1	-1	-2	-4	-7
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-3	-1	-1	-2	-4	-7
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

NewcelX AG (NCEL) Financial

NCEL Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NCEL?

NewcelX AG (NCEL) Financial

NCEL Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NCEL?

NCEL Income

Follow-Up Questions

What are NewcelX AG's key financial statements?

What are the key financial ratios for NCEL?

How is NewcelX AG's revenue broken down by segment or geography?

Is NewcelX AG profitable?

Does NewcelX AG have any liabilities?

How many outstanding shares for NewcelX AG?